Predict your next investment

Asset/Investment Management
hckg.com

See what CB Insights has to offer

Investments

1

About Huacheng Group

Huacheng Group is an investment firm that focuses on real estate, construction materials, market logistics, high-tech materials, and more.

Huacheng Group Headquarter Location

No.308 Fuchun Road, Qianjiang New Town, Jianggan District Huacheng International Development Building

Hangzhou, Zhejiang , 310016,

China

+86 0571-87823820

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Huacheng Group News

China Immunotech Completes $6.5 Million Series A for TCR-T and CAR-T Candidates

Mar 10, 2020

publication date: Mar 10, 2020 China Immunotech Biotech of Beijing completed a $6.5 million Series A financing, led by Jianxin Capital with Grower Venture Capital and Huacheng Group participating. Founded in March 2018, China Immunotech is developing TCR-T and CAR-T products that target hematological tumors, solid tumors and virus-related diseases. It has two unique technology platforms, STAR-T and TCR-T. The STAR-T platform uses a proprietary structure of antigen receptor complexes. The company believes the platform provides multi-targeted molecules with better efficacy, fewer side effects and easier development than traditional CAR-T products. More details.... Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Huacheng Group Investments

1 Investments

Huacheng Group has made 1 investments. Their latest investment was in China Immunotech as part of their Series A on March 3, 2020.

CBI Logo

Huacheng Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/10/2020

Series A

China Immunotech

$6.47M

Yes

4

Date

3/10/2020

Round

Series A

Company

China Immunotech

Amount

$6.47M

New?

Yes

Co-Investors

Sources

4

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.